Author:
Hardin M, ,Cho M H,McDonald M-L,Wan E,Lomas D A,Coxson H O,MacNee W,Vestbo J,Yates J C,Agusti A,Calverley P M A,Celli B,Crim C,Rennard S,Wouters E,Bakke P,Bhatt S P,Kim V,Ramsdell J,Regan E A,Make B J,Hokanson J E,Crapo J D,Beaty T H,Hersh C P,
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference50 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2013. Available from http://d.org/uploa/www.goldcopds/users/files/GOLD_Report_2013_Feb20.pdf (revised 2013).
2. Foreman MG, Campos M, Celedon JC . Genes and chronic obstructive pulmonary disease. Med Clin North Am 2012; 96: 699–711.
3. Ram FS, Sestini P . Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Thorax 2003; 58: 580–584.
4. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31: 742–750.
5. Palmer LJ, Celedon JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK . Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12: 1199–1210.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献